VEGFR2/CD309 Rekombinanter Antikörper
VEGFR2/CD309 Rekombinant Antikörper für WB, Cytometric bead array, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
Maus
Anwendung
WB, Cytometric bead array, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
240214D7
Kat-Nr. : 83366-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83366-1-PBS bindet in WB, Cytometric bead array, Indirect ELISA VEGFR2/CD309 und zeigt Reaktivität mit Maus
| Getestete Reaktivität | Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | VEGFR2/CD309 fusion protein Eg0703 |
| Vollständiger Name | kinase insert domain protein receptor |
| Berechnetes Molekulargewicht | 150KD |
| Beobachtetes Molekulargewicht | 150-190 kDa |
| GenBank-Zugangsnummer | NM_010612.2 |
| Gene symbol | VEGFR-2 |
| Gene ID (NCBI) | 16542 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
VEGFR2, also named CD309, KDR, and FLK1, is a receptor for VEGF or VEGFC. VEGFR2 which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In the case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. VEGFR2 functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis, and sprouting.







